Free Newsletter
Conn. fuels burst of stem cell research programs
Connecticut's decision to funnel $100 million into embryonic stem cell research has fueled a host of research programs in the state. Scientists at UConn, Yale and other research centers say that their work is fast gaining international recognition. The money is buying new scientific equipment that can't qualify for federal funds and attracting top stem cell researchers from around the country. New stem cell lines are being cultivated for research use. And it's all being done with remarkably little controversy. About the only real problem Connecticut has experienced: The panel picked to award grants was overwhelmed by the number of applications it received.
- read the report on Connecticut in The New York Times
Related Articles:
NJ stem cell initiative shot down at the polls. Report
California delivers millions for stem cell research. Report
Top Five Regions Targeting Biotech Companies - 2007. Report
More stories about Stem Cells
Comments
Post new comment
Paid Research Reports
- The Specialty Pharma Market Outlook: Key players, new company growth models and emerging opportunities
- Investigating Clinical Trial Costs: Comparative analysis of trial cost components in key geographies
- Clinical Trial Recruitment Strategies: Optimizing patient recruitment and retention in late stage clinical trials
- Pipeline Insight: Therapeutic Cancer Vaccines - Prospect of first approval set to reinvigorate interest from major companies
- Stakeholder Opinions: Vaccines in Emerging Markets (Asia) - Opportunities in China, India, South Korea and Taiwan
- Big Pharma Performance Before, During and Beyond the Global Recession
